A new approach that may help boost cancer immunotherapy

New research from HICCC member Sankar Ghosh and others reveals that the immune system’s ability to attack cancer may be held back by a type of immune cell known as Treg. In two new papers, one published in the journal Cell and another in the journal Immunity, Dr. Ghosh and colleagues identified a way to hinder Treg’s ability to shield tumors from immune system attack without unleashing an autoimmune response in healthy tissues. The research could provide a new approach to enhancing patient responses to cancer immunotherapies. The CUMC newsroom has more.